Fertility Protocol Design
For couples presenting with infertility, initiate concurrent evaluation of both partners immediately, as male factor contributes to 40-50% of cases, and proceed with a stepwise treatment algorithm based on specific diagnoses, prioritizing assisted reproductive technology (ART) for most conditions while avoiding empiric therapies with limited evidence. 1, 2
Initial Diagnostic Workup
Male Partner Evaluation
- Obtain two semen analyses separated by at least one month (ideally 2-3 months) to confirm persistent abnormalities 3, 4
- Measure serum FSH, LH, and total testosterone to identify correctable endocrine causes 3
- Perform physical examination focusing on:
- If sperm concentration <10 million/mL, order karyotype and Y-chromosome microdeletion analysis before considering ICSI 4
- Document reproductive history including frequency/timing of intercourse, prior fertility, medication use (especially anabolic steroids), and gonadotoxin exposure 4
Female Partner Evaluation
- Assess ovarian reserve and ovulatory function 2
- Evaluate uterine cavity and tubal patency with transvaginal ultrasound as initial imaging 1
- Consider hysterosalpingography or sonohysterography with tubal contrast agent for tubal assessment 1
- Screen for thyroid dysfunction (TSH level), as both hypo- and hyperthyroidism affect ovulation 4
- Calculate BMI, as obesity and extreme thinness reduce fertility rates 1
- Assess for endometriosis, particularly if pelvic pain or dyspareunia present 1
Treatment Algorithm by Diagnosis
Unexplained Infertility (Normal Testing in Both Partners)
- For women <35 years with total motile sperm count (TMSC) >10 million: Initiate 3-4 cycles of intrauterine insemination (IUI) with ovarian stimulation using clomiphene citrate 50 mg daily for 5 days starting cycle day 5 1, 3, 5
- If no pregnancy after 3 IUI cycles or if woman ≥38-40 years: Proceed directly to IVF 3, 6
- Natural cycle IUI without ovarian stimulation has inferior outcomes and should not be used 1
Male Factor Infertility
Low Total Motile Sperm Count (5-10 million)
- Counsel that IUI success rates are significantly reduced with TMSC <5 million; proceed directly to IVF/ICSI 1
- For TMSC 5-10 million, may attempt 1-2 IUI cycles before advancing to IVF/ICSI 1
Asthenozoospermia (Low Motility) or Teratozoospermia
- IVF with intracytoplasmic sperm injection (ICSI) is first-line treatment, as it directly overcomes the motility/morphology defect 3
- Do not delay with empiric medical therapies, as they offer limited benefit compared to ART 1, 3
Clinical Varicocele with Abnormal Semen Parameters
- Offer varicocelectomy to improve fertility rates when female partner has good ovarian reserve 1
- Do not treat subclinical varicocele or varicocele in men with normal semen analysis 1
Hypogonadotropic Hypogonadism (Low FSH, LH, Testosterone)
- Initiate hCG injections to normalize testosterone, then add FSH analogues to optimize spermatogenesis 1, 3
- Refer to endocrinologist or male reproductive specialist 1
- Never prescribe testosterone monotherapy, as it completely suppresses spermatogenesis through negative feedback 1, 3
Idiopathic Infertility with Low-Normal Testosterone
- May consider aromatase inhibitors, hCG, or selective estrogen receptor modulators (SERMs), though benefits are limited relative to ART 1
- Counsel that supplements (antioxidants, vitamins) have questionable clinical utility with inadequate evidence for specific recommendations 1
Azoospermia (No Sperm in Ejaculate)
- For obstructive azoospermia: Microsurgical reconstruction is preferable to sperm retrieval when female partner has normal fertility potential 1
- For non-obstructive azoospermia (NOA): Perform microdissection testicular sperm extraction (micro-TESE) with IVF/ICSI 1
- Micro-TESE achieves successful sperm extraction 1.5 times more often than conventional TESE 1
- Inform NOA patients that pharmacologic manipulation with SERMs, aromatase inhibitors, and gonadotropins has limited data supporting use prior to surgical intervention 1
Female Factor Infertility
Anovulation/Ovulatory Dysfunction
- Start clomiphene citrate 50 mg daily for 5 days beginning cycle day 5 5
- If no ovulation after first cycle, increase to 100 mg daily for 5 days 5
- Do not exceed 100 mg/day for 5 days or continue beyond 6 total cycles 5
- If ovulation occurs but no pregnancy after 3 ovulatory cycles, discontinue clomiphene and proceed to IVF 5
- Letrozole (aromatase inhibitor) is an alternative ovulation induction agent, particularly for PCOS 6
Tubal Factor or Severe Endometriosis
- Proceed directly to IVF, as these conditions preclude natural conception or IUI success 6
Critical Pitfalls to Avoid
- Never prescribe testosterone to men desiring fertility—it causes azoospermia 1, 3
- Do not delay female partner evaluation while treating male factor, as female age critically impacts outcomes 3, 2
- Avoid prolonged empiric medical therapy in males; if no improvement after 3-6 months, advance to ART 1, 3
- Do not use vaginal lubricants, as most commercially available products reduce fertility 1
- Counsel smoking cessation, alcohol limitation, and avoidance of recreational drugs, as these impair fertility 1
- Recognize that male infertility is associated with increased testicular cancer risk and overall mortality; refer abnormal cases to specialists 4
Timing Considerations
- Women ≥35 years warrant expedited evaluation after only 6 months of failed conception 1, 2
- Women ≥40 years require immediate evaluation and consideration of direct IVF 2, 6
- Time intercourse to the 6-day fertile window ending on ovulation day, characterized by stretchy cervical mucus 1
- Recommend intercourse every 1-2 days starting soon after menses ends 1